Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs
about
CD8(+) T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virusIllicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive womenThe Women's Interagency HIV Study: an observational cohort brings clinical sciences to the benchT-cell activation, both pre- and post-HAART levels, correlates with carotid artery stiffness over 6.5 years among HIV-infected women in the WIHSActivation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virusRelationship between complementary/alternative treatment use and illicit drug use among a cohort of women with, or at risk for, HIV infection.Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection.The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use.Presence of hepatitis C virus (HCV) RNA in the genital tracts of HCV/HIV-1-coinfected women.HIV infection, immunodeficiency, viral replication, and the risk of cancer.Permissive and protective factors associated with presence, level, and longitudinal pattern of cervicovaginal HIV sheddingAn investigation of the possible interaction between the use of Vitamin C and highly active antiretroviral therapy (HAART) adherence and effectiveness in treated HIV+ women.Systemic Immune Activation and HIV Shedding in the Female Genital Tract.HIV-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation.Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach.
P2860
Q27486398-1A29BFBE-F97C-4B12-94E8-BBB99F296AA1Q33563439-258CD695-FD76-480C-ADDD-9EB1FF267655Q34045522-060BBB37-A703-40A3-A922-5ED1488EDE87Q34342183-BA52BF3B-AAD8-4B0C-A4B4-CDC2C9F141B0Q35018396-134E2449-5C56-48DE-B430-8927F684B15CQ35033527-FFDC6C8B-FF85-4F73-8A21-7F768649BF7AQ35056266-8ED34A33-34CE-4855-BB9A-BFD4A7C8FC5CQ35082895-46BEEFA3-1629-4661-BBDD-61E915F75A48Q35187467-C7131B08-4F7D-448B-9FFE-9A71A83A17F8Q35612742-C11882DF-FD82-443A-97DB-77A2D62A6176Q35906707-CFD8B758-B2E9-429A-96D5-23F1B24E5E7BQ35957933-CE71CCA4-4367-4941-BC15-14773BCC707FQ36460074-615CA154-48A2-46BB-9D95-0F4B7ED75BF3Q36690021-16C038D3-1675-48BE-AF97-02FB436A6B1DQ37629663-2BAD976C-8C1B-4A4E-BBE8-34B72648F54D
P2860
Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Correlates of immune activatio ...... ve women who use illicit drugs
@ast
Correlates of immune activatio ...... ve women who use illicit drugs
@en
type
label
Correlates of immune activatio ...... ve women who use illicit drugs
@ast
Correlates of immune activatio ...... ve women who use illicit drugs
@en
prefLabel
Correlates of immune activatio ...... ve women who use illicit drugs
@ast
Correlates of immune activatio ...... ve women who use illicit drugs
@en
P2093
P2860
P356
P1476
Correlates of immune activatio ...... ve women who use illicit drugs
@en
P2093
Alan Landay
Andrea Kovacs
Barbara Weiser
Harold Burger
James Bremer
Lorie Benning
Marek Nowicki
P2860
P304
P356
10.1086/376509
P407
P577
2003-07-01T00:00:00Z